Gossamer Bio, Inc.
Gossamer Bio, Inc. (GOSS) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
goss · stock forecast · 17 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 17 Wall Street analysts in the past 3 months
Buy
17 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$1.00
Consensus
$0.77
+338.1% upside
Low
$0.30
Median: $1 · Last Close: $0.17
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$0.77
338.1% upside
High Target
$1
471.4%
Low Target
$0.3
71.4%
Current Price
$0.17
as of today
Based on analyst price targets, the GOSS stock price prediction for the next 12 months ranges from $0.3 to $1. The consensus GOSS price forecast of $0.77 implies 338.1% upside from the current price of $0.17.
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $0.17 | ↓ 5.00% |
1-day model range: $0.16–$0.17. Peak: $0.17 (-5.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · GOSS · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-26 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-19 | Barclays | Maintains | Underweight→Underweight |
| 2026-03-23 | Cantor Fitzgerald | Downgrade ↓ | Overweight→Neutral |
| 2026-03-06 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-05 | Oppenheimer | Maintains | Outperform→Outperform |
| 2026-02-24 | Wedbush | Downgrade ↓ | Outperform→Neutral |
| 2026-02-24 | Barclays | Downgrade ↓ | Overweight→Underweight |
| 2026-02-24 | Leerink Partners | Downgrade ↓ | Outperform→Market Perform |
| 2026-01-22 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-09-11 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Gossamer Bio, Inc. (GOSS) stock. Of the recent 79 rating actions, 1 were upgrades and 8 were downgrades. 17 analysts currently cover GOSS.
Analyst Recommendation Trends
GOSS analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$36M
↓ 72.5% YoY
Revenue Next Year
$53M
↑ 45.7% YoY
EPS This Year
$-0.44
EPS Next Year
$-0.11
↓ 75.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast GOSS EPS of $-0.44 for the current fiscal year, based on estimates from 5 analysts. The GOSS revenue forecast is $36M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The GOSS stock forecast is supported by two independent data sources: analyst consensus ratings from 17 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus GOSS price target is $0.77 (+338.1% upside), with an analyst consensus of Buy.
The GOSS short-term stock prediction for tomorrow is $0.17 (-5.00%).
Gossamer Bio, Inc. trades on NASDAQ under the ticker GOSS. The GOSS stock outlook for 2027 is broadly positive, supported by a Buy consensus among 53% of covering analysts.
Frequently asked questions
GOSS forecast · 8 questionsAccording to 17 Wall Street analysts, the average 12-month GOSS price target is $0.77, with a high forecast of $1.00 and a low of $0.30. The median price target is shown in the chart above when available. This implies +338.1% potential upside from the current price of $0.17.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.